Literature DB >> 25246577

Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process.

Rui Pedro Galvao1, Anita Kasina1, Robert S McNeill2, Jordan E Harbin3, Oded Foreman4, Roel G W Verhaak5, Akiko Nishiyama6, C Ryan Miller7, Hui Zong8.   

Abstract

How malignant gliomas arise in a mature brain remains a mystery, hindering the development of preventive and therapeutic interventions. We previously showed that oligodendrocyte precursor cells (OPCs) can be transformed into glioma when mutations are introduced perinatally. However, adult OPCs rarely proliferate compared with their perinatal counterparts. Whether these relatively quiescent cells have the potential to transform is unknown, which is a critical question considering the late onset of human glioma. Additionally, the premalignant events taking place between initial mutation and a fully developed tumor mass are particularly poorly understood in glioma. Here we used a temporally controllable Cre transgene to delete p53 and NF1 specifically in adult OPCs and demonstrated that these cells consistently give rise to malignant gliomas. To investigate the transforming process of quiescent adult OPCs, we then tracked these cells throughout the premalignant phase, which revealed a dynamic multistep transformation, starting with rapid but transient hyperproliferative reactivation, followed by a long period of dormancy, and then final malignant transformation. Using pharmacological approaches, we discovered that mammalian target of rapamycin signaling is critical for both the initial OPC reactivation step and late-stage tumor cell proliferation and thus might be a potential target for both glioma prevention and treatment. In summary, our results firmly establish the transforming potential of adult OPCs and reveal an actionable multiphasic reactivation process that turns slowly dividing OPCs into malignant gliomas.

Entities:  

Keywords:  cancer; cellular quiescence; cellular reactivation; mTOR signaling

Mesh:

Substances:

Year:  2014        PMID: 25246577      PMCID: PMC4210043          DOI: 10.1073/pnas.1414389111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  84 in total

1.  Gene expression profiling of gliomas strongly predicts survival.

Authors:  William A Freije; F Edmundo Castro-Vargas; Zixing Fang; Steve Horvath; Timothy Cloughesy; Linda M Liau; Paul S Mischel; Stanley F Nelson
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

2.  Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.

Authors:  Da Yong Lee; Tu-Hsueh Yeh; Ryan J Emnett; Crystal R White; David H Gutmann
Journal:  Genes Dev       Date:  2010-09-28       Impact factor: 11.361

3.  Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses.

Authors:  Marcela Assanah; Richard Lochhead; Alfred Ogden; Jeffrey Bruce; James Goldman; Peter Canoll
Journal:  J Neurosci       Date:  2006-06-21       Impact factor: 6.167

4.  mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization.

Authors:  Boyi Gan; Ergün Sahin; Shan Jiang; Abel Sanchez-Aguilera; Kenneth L Scott; Lynda Chin; David A Williams; David J Kwiatkowski; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-03       Impact factor: 11.205

Review 5.  The life, death, and replacement of oligodendrocytes in the adult CNS.

Authors:  Dana M McTigue; Richa B Tripathi
Journal:  J Neurochem       Date:  2008-07-15       Impact factor: 5.372

6.  Transplantation reveals regional differences in oligodendrocyte differentiation in the adult brain.

Authors:  Francesca Viganò; Wiebke Möbius; Magdalena Götz; Leda Dimou
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884

Review 7.  p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.

Authors:  Zhaohui Feng
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

8.  The NF1 tumor suppressor critically regulates TSC2 and mTOR.

Authors:  Cory M Johannessen; Elizabeth E Reczek; Marianne F James; Hilde Brems; Eric Legius; Karen Cichowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

9.  Persistent sonic hedgehog signaling in adult brain determines neural stem cell positional identity.

Authors:  Rebecca A Ihrie; Jugal K Shah; Corey C Harwell; Jacob H Levine; Cristina D Guinto; Melissa Lezameta; Arnold R Kriegstein; Arturo Alvarez-Buylla
Journal:  Neuron       Date:  2011-07-28       Impact factor: 17.173

10.  Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitors.

Authors:  Shibeshih Belachew; Adan A Aguirre; Hang Wang; François Vautier; Xiaoqing Yuan; Stacie Anderson; Martha Kirby; Vittorio Gallo
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

View more
  50 in total

1.  Magnesium sulfate protects oligodendrocyte lineage cells in a rat cell-culture model of hypoxic-ischemic injury.

Authors:  Kanako Itoh; Takakuni Maki; Akihiro Shindo; Naohiro Egawa; Anna C Liang; Naoki Itoh; Eng H Lo; Josephine Lok; Ken Arai
Journal:  Neurosci Res       Date:  2015-12-14       Impact factor: 3.304

2.  Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells.

Authors:  Pítia F Ledur; Chong Liu; Hua He; Alexandra R Harris; Darlan C Minussi; Hai-Yan Zhou; Mark E Shaffrey; Ashok Asthagiri; Maria Beatriz S Lopes; David Schiff; Yi-Cheng Lu; James W Mandell; Guido Lenz; Hui Zong
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

Review 3.  Neuronal Activity in Ontogeny and Oncology.

Authors:  Humsa Venkatesh; Michelle Monje
Journal:  Trends Cancer       Date:  2017-02-13

4.  Frozen tissue preparation for high-resolution multiplex histological analyses of human brain specimens.

Authors:  Fangjie Shao; Wenhong Jiang; Qingqing Gao; Baizhou Li; Chongran Sun; Qiyuan Wang; Qin Chen; Bing Sun; Hong Shen; Keqing Zhu; Jianmin Zhang; Chong Liu
Journal:  J Neurooncol       Date:  2017-08-09       Impact factor: 4.130

5.  Pvr receptor tyrosine kinase signaling promotes post-embryonic morphogenesis, and survival of glia and neural progenitor cells in Drosophila.

Authors:  Renee D Read
Journal:  Development       Date:  2018-12-04       Impact factor: 6.868

Review 6.  Developmental origins and oncogenic pathways in malignant brain tumors.

Authors:  Q Richard Lu; Lily Qian; Xianyao Zhou
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-04-03       Impact factor: 5.814

Review 7.  Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas.

Authors:  Jennifer Kosty; Fanghui Lu; Robert Kupp; Shwetal Mehta; Q Richard Lu
Journal:  Cell Cycle       Date:  2017-08-14       Impact factor: 4.534

Review 8.  Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.

Authors:  Pedro R Lowenstein; Maria G Castro
Journal:  Clin Immunol       Date:  2017-07-15       Impact factor: 3.969

9.  p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.

Authors:  Phillippe P Gonzalez; Jungeun Kim; Rui Pedro Galvao; Nichola Cruickshanks; Roger Abounader; Hui Zong
Journal:  Glia       Date:  2018-02-02       Impact factor: 7.452

10.  Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.

Authors:  Humsa S Venkatesh; Tessa B Johung; Viola Caretti; Alyssa Noll; Yujie Tang; Surya Nagaraja; Erin M Gibson; Christopher W Mount; Jai Polepalli; Siddhartha S Mitra; Pamelyn J Woo; Robert C Malenka; Hannes Vogel; Markus Bredel; Parag Mallick; Michelle Monje
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.